Protagenic Therapeutics, Inc.
Hedge Funds Holdings

Last updated:

Protagenic Therapeutics, Inc.‘s stocks are currently a part of 6 hedge funds’ portfolios, which represents 0.02% of the total amount of its stocks outstanding. This makes up a total of 23.28K shares of Protagenic Therapeutics, Inc.. Compared to the previous quarter, the number fell by -84.77% or -129.58K shares fewer. As for the holding position changes, 133.33% (8) closed the holdings completely. 6 hedge funds are new holders of Protagenic Therapeutics, Inc. stock in Q1 2023, it is 100% of total holders.

Hedge funds holding Protagenic Therapeutics (Q3 2016 – Q1 2023)

Number of hedge funds
Q3 2016 1
Q4 2016 1
Q1 2017 1
Q2 2021 7
Q3 2021 13
Q4 2021 13
Q1 2022 12
Q2 2022 11
Q3 2022 12
Q4 2022 15
Q1 2023 6

Hedge funds changes in Protagenic Therapeutics positions (Q3 2016 – Q1 2023)

Changes in positions
Q3 2016 10000
Q4 2016 00001
Q1 2017 00001
Q2 2021 70000
Q3 2021 73111
Q4 2021 34231
Q1 2022 23331
Q2 2022 22232
Q3 2022 14106
Q4 2022 42414
Q1 2023 6008-8

Top 50 hedge fund holders of Protagenic Therapeutics, Inc. (NASDAQ:PTIX)

Hedge fund Value Shares owned Portfolio share
VANGUARD GROUP INC 145K 252.82K 0.000%
GEODE CAPITAL MANAGEMENT, LLC 59K 103.87K 0.000%
FNY INVESTMENT ADVISERS, LLC 42K 75K 0.029%
STATE STREET CORP 32K 55.24K 0.000%
NORTHERN TRUST CORP 13K 22.48K 0.000%
RENAISSANCE TECHNOLOGIES LLC Jim Simons 12K 21.02K 0.000%
CONCORDE ASSET MANAGEMENT, LLC 10K 16.71K 0.011%
CITADEL ADVISORS LLC Ken Griffin 9K 16.13K 0.000%
VIRTU FINANCIAL LLC 6K 10.58K 0.001%
ADVISOR GROUP HOLDINGS, INC. 6K 11.05K 0.000%
UBS GROUP AG 4K 6.47K 0.000%
TOWER RESEARCH CAPITAL LLC (TRC) 4K 6.52K 0.000%